Angiodynamics (ANGO) Total Current Liabilities (2011 - 2026)
Angiodynamics' (ANGO) quarterly Total Current Liabilities came in at $74.7 million in Q2 2026, down 1.94% YoY from $76.2 million in Q2 2025, and up 13.09% on a QoQ basis from $66.1 million in Q1 2026.
Angiodynamics (ANGO) Total Current Liabilities (2011 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 16 years of Total Current Liabilities data on file, last reported at $74.7 million in Q2 2026.
- Quarterly Total Current Liabilities fell 1.94% year-over-year to $74.7 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $74.7 million (down 1.94% YoY) and the FY2026 annual result came in at $74.7 million, down 1.94% from the prior year.
- Total Current Liabilities improved to $74.7 million in Q2 2026, from $66.1 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $91.2 million in Q2 2024 to a low of $49.4 million in Q1 2022.
- A 5-year average of $73.9 million and a median of $74.5 million in 2022 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Current Liabilities jumped 41.05% — and 2025, when it retreated 18.77%.
- Tracing ANGO's Total Current Liabilities over 5 years: stood at $73.6 million in 2022, then advanced by 6.08% to $78.0 million in 2023, then climbed by 13.53% to $88.6 million in 2024, then retreated by 18.77% to $72.0 million in 2025, then increased by 3.83% to $74.7 million in 2026.
- The last three Total Current Liabilities figures came in at $74.7 million (Q2 2026), $66.1 million (Q1 2026), and $72.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Angiodynamics | 658.19 Mn | 604.32 Mn | 46.77 Mn | 74.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 74.72 Mn |
| Feb 28, 2026 | 66.07 Mn |
| Nov 30, 2025 | 71.96 Mn |
| Aug 31, 2025 | 68.28 Mn |
| May 31, 2025 | 76.20 Mn |
| Feb 28, 2025 | 77.97 Mn |
| Nov 30, 2024 | 88.60 Mn |
| Aug 31, 2024 | 76.70 Mn |
| May 31, 2024 | 91.16 Mn |
| Feb 29, 2024 | 85.87 Mn |
| Nov 30, 2023 | 78.04 Mn |
| Aug 31, 2023 | 57.45 Mn |
| May 31, 2023 | 83.83 Mn |
| Feb 28, 2023 | 69.63 Mn |
| Nov 30, 2022 | 73.57 Mn |
| Aug 31, 2022 | 66.39 Mn |
| May 31, 2022 | 74.32 Mn |
| Feb 28, 2022 | 49.37 Mn |
| Nov 30, 2021 | 54.48 Mn |
| Aug 31, 2021 | 52.10 Mn |